QLUPOD AG: Partnership with Medicare AG Strengthens Market Presence in Switzerland

Herisau (pta011/15.08.2025/19:30 UTC+2)

Released on August 15, 2025 by Qlupod AG

Herisau, Switzerland – August 15, 2025 – Qlupod AG (www.qlupod.com) is pleased to

announce that Medicare AG has added the QluPod to its product portfolio. This strategic

partnership represents an important milestone for the availability and visibility of the innovative

health communicator in the Swiss market.

Medicare AG is one of Switzerland's leading providers of healthcare and nursing products,

renowned for its high-quality range. By adding the QluPod, both resellers and end customers

will benefit from easier access to state-of-the-art telemedicine technology.

"The collaboration with Medicare is of great strategic importance to us. We share the vision of

providing healthcare solutions that sustainably improve people's daily lives. Thanks to

Medicare's strong market position, we can now reach even more customers in Switzerland –

and jointly increase the visibility of the QluPod significantly," says Nikola Trajanov, Interim CEO

and Partner of Qlupod AG.

The QluPod offers an all-in-one solution for mobile health monitoring, including ECG, blood

oxygen, heart rate, temperature, and other vital parameters. It replaces several individual

measuring devices and should be considered an essential health tool in every household. With

its ease of use and secure connection to healthcare professionals, it supports more efficient,

patient-centered care – particularly beneficial for older adults, those with chronic conditions,

as well as health-conscious individuals of all ages.

About Qlupod AG

Qlupod AG is a start-up company in the field of telemedicine and develops innovative solutions

to make patient care efficient and cost-effective. With the QluPod device and the associated

software, the company is endeavouring to shape the future of healthcare. The offering is aimed

at hospitals, care facilities, medical professionals and private individuals who want to monitor

their health independently.

For more information about Qlupod AG and our products, please visit our website at

www.qlupod.com.

Disclaimer:

This publication constitutes neither an offer to sell nor a solicitation to buy securities. Insofar

as this document contains forward-looking statements, these do not represent facts and are

characterised by the words "expect", "believe", "estimate", "intend", "aim", "assume" and

similar expressions. These statements express the intentions, opinions or current expectations

and assumptions of Qlupod AG and are based on current plans, estimates and forecasts which

Qlupod AG has made to the best of its knowledge, but do not claim to be correct in the future.

Forward-looking statements are subject to risks and uncertainties that are difficult to predict

and are generally beyond the control of Qlupod AG. It should be noted that actual events or

developments may differ materially from the events and developments expressed or implied

by such forward-looking statements.

(end)

Emitter:	QLUPOD AG Bahnhofstrasse 23 9100 Herisau Switzerland
Contact Person:	Nikola Trajanov
Phone:	+41 71 510 05 45
E-Mail:	ir@qlupod.com
Website:	qlupod.com
ISIN(s):	CH1222316429 (Share)
Stock Exchange(s):	-
Other Stock Exchanges:	Regelmaessige Kursfeststellung Schweiz